Challenges in Maximizing Impacts of Preventive Strategies Against Respiratory Syncytial Virus (RSV) Disease in Young Children
- Zhe Zheng
PMID: 35782467
Access Resources
About
This article discusses the challenges and advancements in preventive strategies against Respiratory Syncytial Virus (RSV) disease in young children. RSV is a common cause of lower respiratory tract illness in infants and children, leading to significant morbidity and mortality globally. The article highlights the importance of effective RSV vaccines and immune-prophylaxis, focusing on three major preventive strategies: RSV F-protein-based vaccines for pregnant women, extended half-life monoclonal antibodies for neonates, and live-attenuated vaccines for infants. It also addresses the remaining questions in the development and implementation of RSV preventive measures, emphasizing the need for further research and collaboration to maximize vaccine impacts.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.